Abstract
A study in dogs demonstrated that the commercially available formulation of IV levetiracetam (LEV) could be given safely IM and was quickly and completely absorbed. In this crossover study, 5 women and 5 men were given IM and IV LEV. This study demonstrates that administration of 5. ml (500. mg) IM LEV is well tolerated and its bioavailability is equivalent to an IV injection.
Original language | English (US) |
---|---|
Pages (from-to) | 289-292 |
Number of pages | 4 |
Journal | Epilepsy Research |
Volume | 91 |
Issue number | 2-3 |
DOIs | |
State | Published - Oct 2010 |
Bibliographical note
Copyright:Copyright 2011 Elsevier B.V., All rights reserved.
Keywords
- Half-life
- Intramuscular
- Intravenous
- Levetiracetam
- Pharmacokinetics